CURRENT DIRECTIONS IN RESEARCH ON IRRITABLE BOWEL SYNDROME (IBS): PATHOPHYSIOLOGY, DIAGNOSIS, AND THERAPEUTIC PERSPECTIVES
Open Access
- 21 October 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Abstract
This paper provides a comprehensive review of the current state of knowledge on irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, currently classified as a disorder of gut–brain interaction (DGBI). The review discusses the epidemiology, pathophysiology, clinical presentation, diagnostic approach, therapeutic management, and emerging research directions in IBS. The prevalence of IBS ranges from 3.8% to as high as 14% of the global population, with significant regional and sex-related differences. IBS is a multifactorial disorder involving disturbances of the gut–brain axis, visceral hypersensitivity, alterations in the gut microbiota (dysbiosis), immune dysfunction, as well as genetic, hormonal, and psychological factors. The clinical manifestations include recurrent abdominal pain, altered bowel habits (constipation-predominant, diarrhea-predominant, and mixed subtypes), abdominal bloating, and extraintestinal symptoms such as fatigue, sleep disturbances, anxiety, and depression. The diagnosis is based on the Rome IV criteria and the exclusion of organic diseases, particularly in the presence of alarm features ("red flags"). A multidisciplinary therapeutic approach includes patient education, dietary interventions (including the low-FODMAP and Mediterranean diets), probiotics, pharmacological treatment tailored to the IBS subtype, and psychological therapies such as cognitive behavioral therapy (CBT) and gut-directed hypnotherapy. Emerging therapeutic strategies include modulation of the gut microbiota through fecal microbiota transplantation (FMT) and next-generation probiotics, as well as mechanism-based pharmacological agents, including elobixibat and olorinab.Keywords
This publication has 54 references indexed in Scilit:
- Digestive Disease Week 2025The Lancet Gastroenterology & Hepatology, 2025
- Functional gastrointestinal disorders: advances in understanding and managementThe Lancet, 2020
- Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2020
- Pregnancy outcomes in women with severe fear of childbirthJournal of Psychosomatic Research, 2019
- Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilmsInternational Journal for Parasitology, 2017
- Short-term and Long-term Efficacy of Psychological Therapies for Irritable Bowel Syndrome: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2016
- Irritable Bowel SyndromeJAMA, 2015
- Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysisEuropean Archives of Psychiatry and Clinical Neuroscience, 2014
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysisClinical Gastroenterology and Hepatology, 2012
- Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled TrialAmerican Journal of Gastroenterology, 2011